--2026/FY-- / 2.586B--
--2025/FY-- / 2.003B--
--2024/FY1.407B / 1.518B--
--2023/FY1.259B / 1.569B--
--------
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688136 Kexing Biopharm
- 38.52
- +0.72+1.90%
Market Closed Apr 24 15:00 CST
7.69BMarket Cap243.80P/E (TTM)
38.86High36.94Low60.54KlotVolume37.58Open37.80Pre Close228.69MTurnover3.03%Turnover Ratio243.80P/E (Static)199.64MShares42.1052wk High4.70P/B7.69BFloat Cap13.6752wk Low45.36Limit Up199.64MShs Float55.48Historical High30.24Limit Down5.08%Amplitude10.61Historical Low--Dividend TTM37.78Avg Price26.47KlotAsk--Div YieldTTM100Lot Size28.47KlotBid
Kexing Biopharm Key Stats
Kexing Biopharm Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Kexing Biopharm Earnings Reports
Read more
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs